Issue navigation
Volume 37, Issue Supplement_1, September 2024
ISDE 2024 Congress Supplement - Abstracts submitted to the 20th ISDE World Congress for Esophageal Diseases
Abstracts (continued)
396. SHORT-TERM REVIEW: REAL-WORD EXPERIENCE OF PEMBROLIZUMAB AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.151, https://doi.org/10.1093/dote/doae057.151
397. TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITORS AS PRIMARY THERAPY FOR UNRESECTABLE OR RECURRENT ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.152, https://doi.org/10.1093/dote/doae057.152
398. DYSPHAGIA OR REGURGITATION AND ITS CORRELATES AMONG UP TO 10-YEAR ESOPHAGEAL SQUAMOUS CELL CARCINOMA SURVIVORS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.153, https://doi.org/10.1093/dote/doae057.153
399. LYMPH NODE METASTATIC PATTERNS AND SENTINEL LYMPH NODES FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER DIFFERENT NEOADJUVANT REGIMENS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.154, https://doi.org/10.1093/dote/doae057.154
400. MODIFICATION OF THE LESSER CURVATURE INCISION ENHANCES GASTRIC CONDUIT BLOOD FLOW AND DECREASE ANASTOMOTIC LEAKAGE RISK AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.155, https://doi.org/10.1093/dote/doae057.155
401. CLINICAL SIGNIFICANCE OF SIGNAL REGULATORY PROTEIN ALPHA AND CLUSTER OF DIFFERENTIATION 47 EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.156, https://doi.org/10.1093/dote/doae057.156
402. BRAIN METASTASES FROM ESOPHAGEAL CANCER AFTER MULTIMODAL TREATMENT: EARLY DETECTION AND AGGRESSIVE LOCAL TREATMENT CAN LEAD TO BETTER OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.157, https://doi.org/10.1093/dote/doae057.157
403. ROBOTIC-ASSISTED IVOR LEWIS ESOPHAGECTOMY COMPARED TO CONVENTIONAL MINIMALLY INVASIVE ESOPHAGECTOMY: RESULTS FROM SEVEN HIGH VOLUME ITALIAN CENTERS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.158, https://doi.org/10.1093/dote/doae057.158
404. REAL-WORLD TREATMENT PATTERN OF EOSINOPHILIC ESOPHAGITIS IN JAPAN
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.159, https://doi.org/10.1093/dote/doae057.159
405. SELECTIVE ANTERIOR GASTROPEXY WITH OR WITHOUT FUNDOPLICATION FOR THE TREATMENT OF GRADE III/IV HIATAL HERNIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.160, https://doi.org/10.1093/dote/doae057.160
406. EXPLORING THE OPTIMAL TIMING OF MINIMALLY INVASIVE SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.161, https://doi.org/10.1093/dote/doae057.161
407. MICRONUTRIENT INSUFFICIENCY AFTER SURGERY FOR OESOPHAGOGASTRIC NEOPLASMS: A PROSPECTIVE INTERVENTION STUDY CALLED THE VITAMIN STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.162, https://doi.org/10.1093/dote/doae057.162
408. IS DYSPNOEA IN PARAOESOPHAGEAL HERNIA ONLY POST PRANDIAL? RELEVANCE TO THE POST TOOL DEVELOPMENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.163, https://doi.org/10.1093/dote/doae057.163
409. TWO-STAGE OPERATIVE PROCEDURE FOR A BENIGN, COMPLICATED TRACHEOESOPHAGEAL FISTULA CAUSED BY FOREIGN BODY IMPACTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.164, https://doi.org/10.1093/dote/doae057.164
410. THE RELATIONSHIP BETWEEN GASTRIC CONDUIT EMPTYING, FUNCTIONAL ANATOMY AND PERISTALSIS: A DETAILED ANALYSIS USING DYNAMIC MAGNETIC RESONANCE IMAGING
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.165, https://doi.org/10.1093/dote/doae057.165
411. IMPACT OF FEEDING ADJUNCTS AND RADIOLOGICAL SARCOPENIA ON OUTCOMES IN NEO-ADJUVANT TREATED OESOPHAGEAL CANCER PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.166, https://doi.org/10.1093/dote/doae057.166
412. COMPARISON BETWEEN PREOPERATIVE MALNUTRITION, AND SARCOPENIA AND POSTOPERATIVE COMPLICATIONS IN ESOPHAGEAL CANCER PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.167, https://doi.org/10.1093/dote/doae057.167
413. LYMPH NODE MAJOR PATHOLOGIC RESPONSE IS A POTENTIAL PROGNOSTIC FACTOR AFTER NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.168, https://doi.org/10.1093/dote/doae057.168
416. SUCCESSFUL TREATMENT OF ESOPHAGO-MEDIASTINAL FISTULA DUE TO ESOPHAGEAL CANCER WITH IMMUNE CHEMOPOINT INHIBITOR FOLLOWED BY ROBOTIC RADICAL ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.169, https://doi.org/10.1093/dote/doae057.169
417. POSTOPERATIVE CHYLE LEAK - LESS LIKELY IN OBESE PATIENTS AND ASSOCIATED WITH POSTOPERATIVE MORTALITY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.170, https://doi.org/10.1093/dote/doae057.170
420. MESH REINFORCEMENT IN HIATAL HERNIA REPAIR: CLINICAL RESULTS OF OUR EARLY EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.171, https://doi.org/10.1093/dote/doae057.171
421. MODIFIED DOR FUNDOPLICATION IN ACHALASIA PATIENTS: LONG-TERM OUTCOMES FROM A HIGH-VOLUME CENTRE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.172, https://doi.org/10.1093/dote/doae057.172
422. MANAGEMENT OF ANASTOMOTIC LEAK AFTER TOTAL GASTRECTOMY WITH THE “RENDEZ-VOUS” HYBRID TECHNIQUE: PRESENTATION OF OUR APPROACH AND RESULTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.173, https://doi.org/10.1093/dote/doae057.173
423. ROBOTIC SURGERY FOR BENIGN ESOPHAGEAL DISEASE: PROMOSING OUTCOMES OF AN EARLY CASE SERIES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.174, https://doi.org/10.1093/dote/doae057.174
424. EFFECT OF GUT MICROBIOTA ON THE RESPONSE TO NEOADJUVANT IMMUNOTHERAPY COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.175, https://doi.org/10.1093/dote/doae057.175
425. PARACONDUIT HIATAL HERNIA FOLLOWING ESOPHAGECTOMY IN A PORTUGUESE TERTIARY CENTER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.176, https://doi.org/10.1093/dote/doae057.176
426. TAILORED MANAGEMENT OF ANASTOMOTIC LEAK AFTER ESOPHAGECTOMY IN A SPECIALISED UNIT IN THE ERA OF HYBRID AND ENDOSCOPIC NOVELTIES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.177, https://doi.org/10.1093/dote/doae057.177
427. THE ROLE OF CROSS-SECTIONAL IMAGING IN PATIENTS WITH PULMONARY MICRO ASPIRATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.178, https://doi.org/10.1093/dote/doae057.178
428. MIDDLE MEDIASTINAL LYMPHADENECTOMY IN MEDIASTINOSCOPIC ESOPHAGECTOMY FOR ESCC
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.179, https://doi.org/10.1093/dote/doae057.179
429. BARRETT'S ESOPHAGUS IN CHILDREN
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.180, https://doi.org/10.1093/dote/doae057.180
430. PROGNOSTIC PATTERNS OF LYMPH NODES WITH COMPLETE TREATMENT RESPONSE IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY AND NEOADJUVANT CHEMOTHERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.181, https://doi.org/10.1093/dote/doae057.181
431. DISSECTION OF THE SUPRACARINAL MESOESOPHAGUS RECURRENTIAL LYMPHADENECTOMY AND RECURRENT NERVE DAMAGE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.182, https://doi.org/10.1093/dote/doae057.182
432. POSTOPERATIVE SAFETY AND TOLERABILITY OF INTRAMUSCULAR OCTREOTIDE IN PATIENTS WITH GASTROESOPHAGEAL CANCER: AN OPEN-LABEL PHASE 2 PILOT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.183, https://doi.org/10.1093/dote/doae057.183
433. UNRAVELLING THE MOLECULAR MECHANISMS BEHIND TUMOUR DIFFERENTIATION IN ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.184, https://doi.org/10.1093/dote/doae057.184
435. PREVALENCE OF OESOPHAGEAL PREMALIGNANT LESIONS AMONG PATIENTS REFERRED FOR GASTRO-OESOPHAGEAL-DUODENOSCOPY AT A TERTIARY CARE HOSPITAL IN NORTHERN, SRI LANKA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.185, https://doi.org/10.1093/dote/doae057.185
436. IDENTIFICATION OF M6A-RELATED SIGNATURE GENES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA BY MACHINE LEARNING METHOD
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.186, https://doi.org/10.1093/dote/doae057.186
437. MEASUREMENT OF FUNCTIONAL, PSYCHOSOCIAL, AND QUALITY OF LIFE IMPACTS OF ROBOTIC VERSUS HYBRID OESOPHAGO-GASTRECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.187, https://doi.org/10.1093/dote/doae057.187
438. TECHNIQUE OF COMPLETELY ROBOTIC MCKEOWN (3-HOLE) ESOPHAGECTOMY WITH INTRA-CORPOREAL GASTRIC CONDUIT CREATION, AND CERVICAL ESOPHAGO-GASTRIC ANASTOMOSIS FOR MID-ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.188, https://doi.org/10.1093/dote/doae057.188
439. INTEGRATION OF SCRNA-SEQ AND BULK RNA-SEQ TO VALIDATE A PROGNOSTIC ASSOCIATED SIGNATURE IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.189, https://doi.org/10.1093/dote/doae057.189
440. QUANTIFICATION OF FLUORESCENCE ANGIOGRAPHY FOR ESOPHAGEAL PERFUSION ASSESSMENT: MEASURING AGREEMENT BETWEEN TWO SOFTWARE ALGORITHMS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.190, https://doi.org/10.1093/dote/doae057.190
441. EXTENT AND BOUNDARIES OF LYMPH NODE STATIONS DURING MINIMALLY INVASIVE ESOPHAGECTOMY: A SURVEY AMONG DUTCH ESOPHAGEAL SURGEONS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.191, https://doi.org/10.1093/dote/doae057.191
442. POSTOPERATIVE ADJUVANT RADIOTHERAPY REDUCES LOCOREGIONAL RECURRENCE IN PATIENTS WITH BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.192, https://doi.org/10.1093/dote/doae057.192
443. IMPLEMENTATION OF A PROTOCOL FOR THE DIAGNOSIS AND MANAGEMENT OF LONG-TERM COMPLICATIONS FOLLOWING ESOPHAGECTOMY AND GASTRECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.193, https://doi.org/10.1093/dote/doae057.193
444. QUALITY OF LIFE OF CHILDREN AFTER ESOPHAGEAL REPLACEMENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.194, https://doi.org/10.1093/dote/doae057.194
447. SAFETY AND FEASIBILITY OF DOUBLE FLAP RECONSTRUCTION (KAMIKAWA TECHNIQUE) AS ANTI-REFLUX MECHANISM AFTER GASTROESOPHAGEAL SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.195, https://doi.org/10.1093/dote/doae057.195
448. PREOPERATIVE PEMBROLIZUMAB COMBINED WITH CHEMOTHERAPY FOR THORACIC ESCC WITH CERVICAL LYMPH NODE METASTASIS (PICC-1): A PROSPECTIVE, PHASE 2 STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.196, https://doi.org/10.1093/dote/doae057.196
449. CAN LARGE ANASTOMOTIC LEAKAGE AFTER ESOPHAGEAL SURGERY BE TREATED BY ENDOLUMINAL VACUUM-ASSISTED CLOSURE (EVAC THERAPY)?: A CASE REPORT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.197, https://doi.org/10.1093/dote/doae057.197
450. TISSUE RESIDENT MEMORY CELLS: CORRELATING THE PHENOTYPIC AND FUNCTIONAL CAPABILITIES OF A POTENTIAL TUMOUR REACTIVE CELL POPULATION IN OESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.198, https://doi.org/10.1093/dote/doae057.198
451. PREDICTIVE FACTORS FOR PNEUMONIA AND ANASTOMOTIC LEAK AFTER TRANSTHORACIC ESOPHAGECTOMY FOR CANCER AND FAILURE TO RESCUE ANALYSIS ON 1355 PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.199, https://doi.org/10.1093/dote/doae057.199
452. THE TREATMENT STRATEGY FOR RECURRENT OR UNRESECTABLE ESOPHAGEAL CANCER USING IMMUNE CHECKPOINT INHIBITORS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.200, https://doi.org/10.1093/dote/doae057.200
453. ROBOT ESOPHAGECTOMY WITH EXTENDED MEDIASTINAL LYMPH NODE DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.201, https://doi.org/10.1093/dote/doae057.201
454. QUALITY OF LIFE AFTER ESOPHAGECTOMY WITH INTRATHORACIC VS CERVICAL ANASTOMOSIS: A NATIONWIDE COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.202, https://doi.org/10.1093/dote/doae057.202
455. SHOULD THE DIAGNOSTIC THRESHOLD FOR PH MONITORING IN GASTROESOPHAGEAL REFLUX DISEASE DIFFER BETWEEN THE EAST AND THE WEST?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.203, https://doi.org/10.1093/dote/doae057.203
457. EVALUATING THE ACCURACY OF CLINICAL SIEWERT CLASSIFICATION, A RETROSPECTIVE REVIEW OF 807 PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.204, https://doi.org/10.1093/dote/doae057.204
458. THORACOSCOPY VERSUS ENDOSCOPY IN THE TREATMENT OF ESOPHAGEAL LEIOMYOMA: A SINGLE-CENTER RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.205, https://doi.org/10.1093/dote/doae057.205
459. DIAPHRAGMATIC RELAXING INCISION IN THE REPAIR OF DIAPHRAGMATIC HERNIA FOLLOWING OESOPHAGECTOMY: A RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.206, https://doi.org/10.1093/dote/doae057.206
460. THE ADDITIONAL VALUE OF CERVICAL ULTRASOUND IN THE DETECTION OF CERVICAL LYMPH NODE METASTASES IN PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.207, https://doi.org/10.1093/dote/doae057.207
461. BARRETT'S ESOPHAGUS POST-ABLATION TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) WITH OR WITHOUT HIATAL HERNIA REPAIR (CTIF):A PROSPECTIVE FEASIBILITY TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.208, https://doi.org/10.1093/dote/doae057.208
462. EPIPHRENIC DIVERTICULA. THERAPEUTIC ALTERNATIVES AND OUR EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.209, https://doi.org/10.1093/dote/doae057.209
463. ISOFORM SWITCHING EVENTS IN ESOPHAGEAL ADENOCARCINOMA MAY INFORM NEW THERAPEUTIC TARGETS THROUGH IDENTIFYING MOLECULAR MECHANISMS CONTRIBUTING TO POOR PATIENT OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.210, https://doi.org/10.1093/dote/doae057.210
464. OUTCOMES AFTER CURATIVE RESECTION FOR GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.211, https://doi.org/10.1093/dote/doae057.211
465. INNOVATION TO STANDARDIZATION OF THORACOLAPAROSCOPIC ESOPHAGECTOMY: CULMINATION OF THREE DECADES OF EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.212, https://doi.org/10.1093/dote/doae057.212
466. ROBOT-ASSISTED CERVICAL ESOPHAGECTOMY (RACE) FOR ESOPHAGEAL CANCER: THE FIRST TWO CASES OF AN ITALIAN HIGH-VOLUME CENTER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.213, https://doi.org/10.1093/dote/doae057.213
467. DISTRIBUTION OF LYMPH NODE INVOLVEMENT IN PATIENTS WITH GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.214, https://doi.org/10.1093/dote/doae057.214
468. CALCULATING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE FOR THE FACT-E FROM ESOPHAGECTOMY TO RECOVERY USING DISTRIBUTION-BASED METHODS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.215, https://doi.org/10.1093/dote/doae057.215
470. INTENSIVE EARLY SURVEILLANCE FOLLOWING ESOPHAGECTOMY IDENTIFIES DISTINCT PATTERNS OF RECURRENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.216, https://doi.org/10.1093/dote/doae057.216
471. MANAGEMENT OF EARLY ESOPHAGEAL CANCER - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.217, https://doi.org/10.1093/dote/doae057.217
474. SELF EXPANDABLE METAL STENT AS A BRIDGE TO RESECTION IN ESOPHAGEAL CANCER – A NATIONAL REGISTER ANALYSIS ON MORTALITY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.218, https://doi.org/10.1093/dote/doae057.218
475. MINIMALLY INVASIVE IVOR -LEWIS ESOPHAGECTOMY - ANALYSIS OF PERIOPERATIVE ONCOLOGICAL AND SHORT TERM OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.219, https://doi.org/10.1093/dote/doae057.219
478. OVERVIEW ON USE OF THE TRANSCERVICAL MEDIASTINOSCOPIC APPROACH FOR MINIMALLY INVASIVE TREATMENT OF ESOPHAGEAL CANCER: ESTABLISHMENT OF INTERNATIONAL COLLABORATIVE GROUP
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.220, https://doi.org/10.1093/dote/doae057.220
481. STRONG SYMPTOMATIC IMPROVEMENT AT 1 YEAR AND BEYOND FOLLOWING REFLUXSTOP SURGERY FOR GASTRO-ESOPHAGEAL REFLUX DISEASE: A 40-PATIENT COHORTT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.221, https://doi.org/10.1093/dote/doae057.221
482. REFLUXSTOP PROCEDURE IN THE LAPAROSCOPIC REPAIR OF HIATAL HERNIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.222, https://doi.org/10.1093/dote/doae057.222
484. DELTA-IRP AS A NEW HIGH-RESOLUTION MANOMETRY METRIC TO PREDICT THE POSITIVE OUTCOME OF LAPAROSCOPIC HELLER-DOR IN PATIENTS WITH ACHALASIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.223, https://doi.org/10.1093/dote/doae057.223
485. OMENTOPLASTY AS AN ADJUNCT IN ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.224, https://doi.org/10.1093/dote/doae057.224
487. A RARE CASE OF BRONCHOGENIC CYST ESOPHAGUS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.225, https://doi.org/10.1093/dote/doae057.225
489. EVALUATION OF THE ONCOLOGICAL QUALITY OF MINIMALLY INVASIVE TRANSCERVICAL OESOPHAGECTOMY (MICE) USING A CADAVERIC MODEL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.226, https://doi.org/10.1093/dote/doae057.226
490. THE IMPACT OF ONE-LUNG VENTILATION ON POSTOPERATIVE COMPLICATIONS AFTER IVOR LEWIS ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.227, https://doi.org/10.1093/dote/doae057.227
491. STEP BY STEP INTRATHORACIC HAND-SEWN ESOPHAGOGASTRIC ANASTOMOSIS DURING TOTALLY ROBOTIC MINIMALLY INVASIVE TWO-STAGE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.228, https://doi.org/10.1093/dote/doae057.228
492. OUTCOMES OF ESOPHAGECTOMY IN THE ELDERLY- IS IT WORTH THE EFFORT?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.229, https://doi.org/10.1093/dote/doae057.229
493. EFFECTIVENESS OF TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) WITHOUT OR WITH HIATAL HERNIA REPAIR (CTIF) IN PATIENTS WITH GERD AND CHRONIC COUGH
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.230, https://doi.org/10.1093/dote/doae057.230
494. DO WE NEED GENDER SPECIFIC GUIDELINES FOR ESOPHAGEAL CANCER MANAGEMENT?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.231, https://doi.org/10.1093/dote/doae057.231
495. LAPAROSCOPIC FUNDOPLICATION IMPROVES ESOPHAGEAL MOTILITY IN PATIENTS WITH GERD A HIGH VOLUME SINGLE CENTER CONTROLLED STUDY IN HIGH-RESOLUTION MANOMETRY ERA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.232, https://doi.org/10.1093/dote/doae057.232
496. OESOPHAGEAL STENTING IN BOERHAAVE SYNDROME: OUR EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.233, https://doi.org/10.1093/dote/doae057.233
497. ENDOFLIP AND BOTULIN TOXIN INJECTION: THERAPEUTIC MANAGEMENT IN ESOPHAGEAL AND GASTRIC MOTILITY DISORDERS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.234, https://doi.org/10.1093/dote/doae057.234
498. LATROGENIC ESOPHAGEAL DISEASE POST OBESITY TREATMENT: SEVERE ESOPHAGEAL DILATATION RELATED TO ADJUSTABLE GASTRIC BANDING (AGB)
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.235, https://doi.org/10.1093/dote/doae057.235
500. PRIMARY ESOPHAGEAL LYMPHOMA: UNDERSTANDING PROGNOSTIC FACTORS AND OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.236, https://doi.org/10.1093/dote/doae057.236
501. CLINICAL APPLICATION OF OESOPHAGEAL CELL COLLECTION DEVICE AND BIOMARKER TESTING IN SYMPTOMATIC REFLUX DISEASE: A NATIONAL RETROSPECTIVE COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.237, https://doi.org/10.1093/dote/doae057.237
502. COMPARING NEOADJUVANT TREATMENTS REGARDING DYSPHAGIA AND WEIGHT CHANGES FOR PATIENTS WITH OESOPHAGEAL OR GASTRO OESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.238, https://doi.org/10.1093/dote/doae057.238
503. HEALTH-RELATED QUALITY OF LIFE FOLLOWING CURATIVE INTENT TREATMENT FOR ESOPHAGEAL CANCER: IMPACT OF TREATMENT PATHWAY ON PATIENT-REPORTED OUTCOMES IN SURVIVORSHIP
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.239, https://doi.org/10.1093/dote/doae057.239
504. SENTINEL LYMPH NODE NAVIGATED SURGERY IN ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA USING INDOCYANINE GREEN AND FLUORESCENCE IMAGING
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.240, https://doi.org/10.1093/dote/doae057.240
505. USE OF INDOCYANINE GREEN FOR ASSESSMENT OF GASTROPLASTY VASCULARIZATION AFTER MCKEOWN ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.241, https://doi.org/10.1093/dote/doae057.241
506. CLINICAL OUTCOMES OF A NEW SURGICAL TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE: RETROSPECTIVE CHART REVIEW OF 28 PATIENTS FROM GERMANY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.242, https://doi.org/10.1093/dote/doae057.242
507. LONG BARRETT´S ESOPHAGUS IN MONOZYGOTIC TWINS WITH ADENOCARCINOMA DEVELOPMENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.243, https://doi.org/10.1093/dote/doae057.243
509. DOES SARCOPENIA AFFECT THE OUTCOME OF PATIENTS WITH ESOPHAGEAL CARCINOMA AFTER ESOPHAGECTOMY?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.244, https://doi.org/10.1093/dote/doae057.244
510. INNOVATIVE ROBOTIC-ASSISTED ESOPHAGECTOMY WITH THREE-FIELD LYMPHADENECTOMY: A NOVEL APPROACH TO ESOPHAGEAL CANCER SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.245, https://doi.org/10.1093/dote/doae057.245
511. IS IT SAFE TO USE NONABSORBABLE MESH IMPLANTATION FOR HIATAL REINFORCEMENT DURING PRIMARY ANTIREFLUX PROCEDURES?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.246, https://doi.org/10.1093/dote/doae057.246
513. ICG -TRACHEOBRONCHIAL FLUORESCENCE IN ESOPHAGEAL SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.247, https://doi.org/10.1093/dote/doae057.247
514. ESOPHAGOGASTRIC ANASTOMOSIS STRICTURE AFTER A CERVICAL FISTULA: LONG TERM COMPLICATION AFTER THE MCKEOWN PROCEDURE STERNOTOMY APPROACH: ANASTOMOSIS RESECTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.248, https://doi.org/10.1093/dote/doae057.248
515. LAPAROSCOPIC PHARYNGO-COLOPLASTY WITH RIGHT COLON FOR A CASE OF COROSSIVE INJURY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.249, https://doi.org/10.1093/dote/doae057.249
516. HELLER MYOTOMY FOR SYMPTOMATIC ACHALASIA: TRADITIONAL LAPAROSCOPY OR ROBOTICS? A SYSTEMATIC REVIEW WITH META-ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.250, https://doi.org/10.1093/dote/doae057.250
517. INTERNATIONAL CONSENSUS AND CLINICAL CARE ALGORITHM FOR THE DIAGNOSIS AND TREATMENT OF ANASTOMOTIC LEAK AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.251, https://doi.org/10.1093/dote/doae057.251
518. ARTIFICIAL INTELLIGENCE MODELS VS CLINICIAN PERSPECTIVES OF IMPORTANT FACTORS IN OESOPHAGEAL CANCER DECISION-MAKING
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.252, https://doi.org/10.1093/dote/doae057.252
519. ROBOTIC HELLER DOR FOR SYMPTOMATIC ACHALASIA. A SINGLE TERTIARY CENTER EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.253, https://doi.org/10.1093/dote/doae057.253
520. TEMPORARY ESOPHAGEAL EXCLUSION IN THE MANAGEMENT OF DELAYED RECOGNITION OF THORACIC ESOPHAGEAL PERFORATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.254, https://doi.org/10.1093/dote/doae057.254
521. SHORT-TERM PROPHYLACTIC STENTING FOR HIGH-RISK ESOPHAGEAL ANASTOMOSIS: A CASE SERIES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.255, https://doi.org/10.1093/dote/doae057.255
522. MULTI-SLICE, VOLUMETRIC COMPUTED TOMOGRAPHY BODY COMPOSITION ANALYSIS IN PATIENTS WITH OESOPHAGOGASTRIC CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.256, https://doi.org/10.1093/dote/doae057.256
523. FIVE YEARS OF FLOT THERAPY. RANDOMIZED CONTROLLED TRIAL EVIDENCE IN PRACTICE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.257, https://doi.org/10.1093/dote/doae057.257
524. SURVIVAL AFTER CURATIVELY INTENDED TREATMENT OF ESOPHAGEAL CANCER IN THE NORDIC COUNTRIES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.258, https://doi.org/10.1093/dote/doae057.258
525. PALLIATIVE MULTIMODALITY-THERAPY, EVEN WITH ABBREVIATED IMMUNOTHERAPY CAN MAKE CURATIVE SURGERY FOR SYNCHRONOUS LUNG AND ESOPHAGEAL CANCER POSSIBLE: A CASE REPORT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.259, https://doi.org/10.1093/dote/doae057.259
526. COMPARISON OF CANCER CACHEXIA DEFINITIONS AND THEIR ASSOCIATION WITH OVERALL SURVIVAL IN PATIENTS WITH INCURABLE OESOPHAGOGASTRIC CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.260, https://doi.org/10.1093/dote/doae057.260
527. SURGERY FOLLOWING ENDOSCOPIC RESECTION OF EARLY OESOPHAGO-GASTRIC CANCER AT ONE LARGE TERTIARY UNIT: A RETROSPECTIVE AUDIT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.261, https://doi.org/10.1093/dote/doae057.261
528. IMPACT OF SARCOPENIA AND MYOSTEATOSIS ON THE SURGICAL OUTCOME OF PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.262, https://doi.org/10.1093/dote/doae057.262
532. OPERATIVE TRENDS AND CLINICAL OUTCOMES OF OPEN, LAPAROSCOPIC AND ROBOTIC APPROACHES TO HIATAL AND PARAOESOPHAGEAL HERNIAS-A STUDY OF 1834 PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.263, https://doi.org/10.1093/dote/doae057.263
534. EVALUATION OF SURGICAL OUTCOMES IN ROBOTIC-ASSISTED ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.264, https://doi.org/10.1093/dote/doae057.264
535. AUDITING THE PATIENTS OUTCOMES AFTER SURGERY FOR ESOPHAGEAL AND GASTRIC CARDIA CANCER WITHIN THE 18 YEARS PERIOD. SINGLE CENTER EXPERIENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.265, https://doi.org/10.1093/dote/doae057.265
536. TUMOR-INFORMED “LIQUID BIOPSY” FOR ESOPHAGEAL ADENOCARCINOMA FROM MATCHED CANCER ORGANOID CULTURE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.266, https://doi.org/10.1093/dote/doae057.266
537. ASSESSING THE EFFECT OF HIATAL HERNIA SIZE ON PERIOPERATIVE OUTCOMES AND HOSPITAL READMISSION RATES AFTER PRIMARY REPAIR
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.267, https://doi.org/10.1093/dote/doae057.267
538. COMPARISON OF EARLY POSTOPERATIVE OUTCOMES OF CERVICAL ANASTOMOSIS TO HIGH INTRATHORACIC ANASTOMOSIS AMONG PATIENTS WITH UPPER THORACIC ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.268, https://doi.org/10.1093/dote/doae057.268
539. ASSOCIATION BETWEEN WAITING PERIOD FOR RADICAL SURGERY AND POSTOPERATIVE RELAPSE IN CLINICAL STAGE I ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.269, https://doi.org/10.1093/dote/doae057.269
540. INFILTRATION OF RESECTED OESOPHAGEAL ADENOCARCINOMA WITH ANTIGEN-EXPERIENCED PD-1 AND CD39 POSITIVE CD8+ TISSUE RESIDENT MEMORY CELLS CORRELATE WITH IMPROVED SURVIVAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.270, https://doi.org/10.1093/dote/doae057.270
541. THE PHOENIX-HH SCORE: A TOOL TO PREDICT ADMISSION TO THE ICU AFTER HIATAL HERNIA REPAIR
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.271, https://doi.org/10.1093/dote/doae057.271
542. POST-ESOPHAGECTOMY PARACONDUIT HIATAL HERNIA DEVELOPMENT AND RECURRENCE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.272, https://doi.org/10.1093/dote/doae057.272
545. HIATAL HERNIA RECURRENCE: IS OBSTRUCTIVE SLEEP APNEA A RISK FACTOR?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.273, https://doi.org/10.1093/dote/doae057.273
546. ESOPHAGEAL FUNCTION TESTS BEFORE AND AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY FOR SEVERE OBESITY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.274, https://doi.org/10.1093/dote/doae057.274
547. DISEASE SPECIFIC MORTALITY OF EARLY-STAGE ESOPHAGEAL NEOPLASIA IN BARRETT’S ESOPHAGUS TREATED WITH ENDOSCOPIC THERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.275, https://doi.org/10.1093/dote/doae057.275
549. CLINICAL IMPLICATIONS OF SELECTIVE RIGHT PARATRACHEAL LYMPH NODE DISSECTION IN PATIENTS WITH EARLY-STAGE ESOPHAGEAL CANCER: PROPENSITY-SCORE MATCHED ANAYLSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.276, https://doi.org/10.1093/dote/doae057.276
550. INTRAOPERATIVE VOLUME STATUS DOES NOT AFFECT ERAS OUTCOMES OR COMPLICATION RATES IN HYBRID ROBOTIC ASSISTED MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.277, https://doi.org/10.1093/dote/doae057.277
552. COMPARING ROBOTIC ESOPHAGECTOMY TO VIDEO-ASSISTED THORACOSCOPIC ESOPHAGECTOMY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: RESULTS FROM THE REVATE RANDOMIZED CLINICAL TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.278, https://doi.org/10.1093/dote/doae057.278
553. CIRCULAR STAPLED CERVICAL ESOPHAGO-GASTROSTOMY, A VALUABLE OPTION AFTER TOTALLY MINIMALLY INVASIVE MCKEOWN ESOPHAGECTOMY?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.279, https://doi.org/10.1093/dote/doae057.279
554. SHORT TERM OUTCOMES OF ESOPHAGECTOMY FROM LOW VOLUME CANCER CENTRE IN INDIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.280, https://doi.org/10.1093/dote/doae057.280
555. SUPRACLAVICULAR NODE INVOLVEMENT, A NODAL OR METASTATIC DISEASE? - A 10-YEAR EXPERIENCE IN ESOPHAGEAL CARCINOMA AT A TERTIARY REFERRAL CENTRE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.281, https://doi.org/10.1093/dote/doae057.281
556. PREDICTORS OF EARLY RECURRENCE AFTER OESOPHAGECTOMY AND NEOADJUVANT FLOT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.282, https://doi.org/10.1093/dote/doae057.282
557. POTENTIAL THERAPEUTIC TARGETS OF TRPV2 AND SLC12A2 IN ESOPHAGEAL ADENOCARCINOMA CANCER STEM CELLS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.283, https://doi.org/10.1093/dote/doae057.283
559. SURGICAL PROCEDURE AND CLINICAL OUTCOME OF TRANSMEDIASTINAL ESOPHAGECTOMY FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.284, https://doi.org/10.1093/dote/doae057.284
560. ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS OF SYNCHRONOUS MULTIPLE PRIMARY ESOPHAGEAL SQUAMOUS CELL CARCINOMAS (SMP-ESCC) AFTER RECEIVING NEOADJUVANT THERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.285, https://doi.org/10.1093/dote/doae057.285
561. COMMONALITY AND VARIATION IN PERIOPERATIVE ESOPHAGEAL CANCER MANAGEMENT IN HIGH VOLUME EUROPEAN CENTERS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.286, https://doi.org/10.1093/dote/doae057.286
562. COMPARATIVE ANALYSIS OF THE OUTCOMES OF GASTRECTOMY VS. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR THE TREATMENT OF GASTRIC TUBE CANCER AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.287, https://doi.org/10.1093/dote/doae057.287
563. CURRENT AND PROPOSED TREATMENT STRATEGIES FOR LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.288, https://doi.org/10.1093/dote/doae057.288
564. PRONE POSITION THORACOSCOPIC HAND-SEWN ESOPHAGO-GASTRIC ANASTOMOSIS DURING 2-STAGE TOTALLY MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER. SURGICAL TECHNIQUE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.289, https://doi.org/10.1093/dote/doae057.289
565. LAPAROSCOPIC TREATMENT OF HIATAL HERNIAS COMBINED WITH MODIFIED TOUPET FUNDOPLICATION. SURGICAL TECHNIQUE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.290, https://doi.org/10.1093/dote/doae057.290
566. SUPERIOR MEDISTINAL LYMPHADENECTOMY IN PRONE POSITION UTILIZING 3D-ASSISTED THORACOSCOPY. A NOVEL APPROACH
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.291, https://doi.org/10.1093/dote/doae057.291
567. EPIDEMIOLOGY OF BARRETT'S ESOPHAGUS IN ICELAND; INCIDENCE AND PROGRESSION TO NEOPLASM FROM A LARGE POPULATION-BASED STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.292, https://doi.org/10.1093/dote/doae057.292
569. PROGNOSTIC VALUE OF T CELL PHENOTYPES AND PD-L1 EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.293, https://doi.org/10.1093/dote/doae057.293
570. ADRENAL METASTASES OF ESOPHAGEAL CANCER: SURGICAL MANAGEMENT OF SINGLE METASTASES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.294, https://doi.org/10.1093/dote/doae057.294
571. A PHASE I/II MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF INDUCTION IMMUNOCHEMOTHERAPY FOLLOWED BY CONCURRENT IMMUNO-CHEMORADIOTHERAPY IN UNRESECTABLE LA-ESCC
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.295, https://doi.org/10.1093/dote/doae057.295
572. TECHNICAL DETAIL AND SHORT-TERM OUTCOMES OF ROBOT-ASSISTED CERVICAL ESOPHAGECTOMY (RACE) WITH BILATERAL CERVICAL APPROACH FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.296, https://doi.org/10.1093/dote/doae057.296
573. SHORT- AND LONG-TERM RESULTS OF RAMIE IN BORDERLINE CT3 /T4B ESOPHAGEAL CANCER AT INITIAL DIAGNOSIS: COMPARISON WITH CONVENTIONAL MIE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.297, https://doi.org/10.1093/dote/doae057.297
575. PATHOLOGIC RESPONSE AND RESIDUAL LYMPH NODE PATTERNS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENTS UNDERGOING NEOADJUVANT IMMUNOCHEMOTHERAPY COMPARED TO NEOADJUVANT CHEMORADIOTHERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.298, https://doi.org/10.1093/dote/doae057.298
577. OUTCOMES OF SIMULTANEOUS RESECTION AND RECONSTRUCTION OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA SYNCHRONOUSLY ASSOCIATED WITH HEAD AND NECK CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.299, https://doi.org/10.1093/dote/doae057.299
578. DUPILUMAB EFFICACY IN EOSINOPHILIC OESOPHAGITIS PATIENTS TREATED WITH PRIOR THERAPY AND INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.300, https://doi.org/10.1093/dote/doae057.300
